Global Business Reports


Alfonso Tejerina, Lina Jafari

Gujarat Pharmaceuticals 2020

August 25, 2020

Climate and geography have long pushed Gujarat towards commerce. Poor rainfall made it hard to scratch out a living by farming, so that other industries were developed to pay the bills. 

With its long coastline of 1,600 kilometers and a border with Pakistan, the region was a natural hub for international trade. As a result of lucrative trading relationships, the state has long been one of India’s most prosperous. Today, Gujarat is an industrialized hub with its main commercial city, Ahmedabad, nicknamed “Manchester of India” on account of its huge textile industry. 

Gujarat has also been the flag bearer of India’s pharmaceutical industry since the establishment of the country’s second oldest drug company, the Alembic Chemical Works Company, in Vadodara in 1907. According to Dr. H.G. Koshia, commissioner of FDCA Gujarat, the state regulatory body for pharmaceutical drug approvals, the Gujarat model has allowed pharma companies to thrive.


Powered by its XmAb antibody engineering platform, Xencor is developing a broad pipeline of drug candidates that are optimized to treat autoimmune disorders, cancer, asthma and allergic diseases.
Piramal Pharma updates GBR in its recent developments and prospects.
Tango Therapeutics is targeting unaddressed disease mechanisms in cancer to develop transformational new drugs for patients.
Founded in 2008, Eiger BioPharmaceuticals is a late-stage biopharmaceutical company focused on developing and commercializing targeted therapies for rare diseases.


Robinson International explains conditions for its analysis and testing operations in DRC.